In collaboration with Martin Pomper group (Johns Hopkins Medical Institutions, Baltimore, USA) we filed a USPTO describing the development of new monoclonal antibodies recognizing human prostate-specific membrane antigen. The antibodies can be used for imaging and therapy of prostate cancer and solid tumors. Further development and licensing is in progress.
In collaboration with Goldman group (Georgetown University, D.C., USA) we published a manucript detailing the distribution of the site-specific glycoforms…
Warm welcome to Tereza, the second year student at the department Molecular biology and biochemistry of organisms, who joined our…
In collaboration with the Institute of Organic Chemistry and Biochemistry and the Immunotech company, we have developed an ELISA assay…
Congratulation to Anastasia and Zsofia on their manuscript just accepted to Nat Commun! The paper describes the development and structural…
Congratulation to Jana, who received a 3-month internship from Instruct! Her proposal is aimed at eludidating a structure of a…
Congratulations to Anastasia on her successful MSc defense and graduation at the Department of Physical and Macromolecular Chemistry, Faculty of…
Congratulations to Jana for successfully passing her PhD Qualifying Exam in Biochemistry today!! Great job!!
Congratulations to Gargi for successfully passing her PhD Qualifying Exam in Immunology today!! Great job!!
As a collaborative project of several groups with complementary expertise, we report the discovery of SW-101, a new HDAC6 inhibitor…
Congratulation to Gargi on her GAUK grant focused on the development of antibody plaforms targeting human prostate-specific membrane antigen (PSMA)…
(c) 2013, Laboratory of Structural Biology | admin
